The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery

Abstract

Sunitinib as initial therapy in patients with locally advanced features of the primary tumor was feasible and resulted in an antitumor effect that enabled subsequent surgery in a subset of patients. Further prospective study is required to refine the most suitable application of this approach.